Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
BIO Bio-Rad Laboratories
- 265.160
- -0.470-0.18%
Close Feb 28 16:00 ET
- 265.160
- 0.0000.00%
Post 16:55 ET
7.43BMarket Cap-4.06P/E (TTM)
269.300High262.110Low301.78KVolume267.330Open265.630Pre Close79.99MTurnover1.55%Turnover RatioLossP/E (Static)28.01MShares387.99052wk High1.13P/B5.16BFloat Cap262.11052wk Low--Dividend TTM19.44MShs Float832.700Historical High--Div YieldTTM2.71%Amplitude9.438Historical Low265.066Avg Price1Lot Size
Bio-Rad Laboratories Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.42%455.2M | 53.33%124.2M | 67.45%163.6M | -0.51%97.6M | -28.85%69.8M | 92.85%374.9M | 1.76%81M | 788.18%97.7M | 84.05%98.1M | 94.26%98.1M |
| Net income from continuing operations | -189.38%-1.84B | -304.69%-715.8M | 514.49%653.2M | -86.31%-2.17B | 456.38%383.9M | 82.43%-637.3M | -57.76%349.7M | 165.29%106.3M | -25.63%-1.16B | 102.05%69M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -78.57%-2.5M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 3.91%151.6M | 5.38%39.2M | 4.29%38.9M | 1.68%36.4M | 4.21%37.1M | 6.26%145.9M | 4.79%37.2M | 8.75%37.3M | 4.99%35.8M | 6.59%35.6M |
| Other non cash items | 512.50%49.5M | 86.29%23.85M | 223.35%28.11M | -139.56%-4.15M | 702.14%1.69M | -154.30%-12M | 21.83%12.8M | -415.33%-22.79M | -146.01%-1.73M | -147.31%-281K |
| Change In working capital | -43.44%-620.8M | -2,534.15%-216M | 8,928.00%220.7M | -77.97%-679.5M | 234.00%54M | 73.12%-432.8M | -105.58%-8.2M | 98.55%-2.5M | 6.83%-381.8M | 96.57%-40.3M |
| -Change in receivables | 42.11%16.2M | 53.47%-9.4M | -128.03%-7.4M | -166.67%-4.4M | 2,771.43%37.4M | 113.04%11.4M | 52.91%-20.2M | 1,930.77%26.4M | 560.00%6.6M | 97.01%-1.4M |
| -Change in inventory | 118.36%8.5M | 59.09%24.5M | 337.50%15.2M | 11.11%-22.4M | 70.76%-8.8M | 70.84%-46.3M | 287.80%15.4M | 86.75%-6.4M | 62.28%-25.2M | 15.21%-30.1M |
| -Change in payables and accrued expense | 77.02%-16.8M | 75.13%-14.2M | 243.75%18.4M | 150.92%11.1M | -272.58%-32.1M | 23.38%-73.1M | -522.96%-57.1M | 69.88%-12.8M | 38.24%-21.8M | 159.81%18.6M |
| -Change in other current assets | -494.74%-7.5M | 78.63%-2.8M | 1,853.33%26.3M | -114.46%-4.7M | -64.38%-26.3M | 105.86%1.9M | 36.10%-13.1M | -7.14%-1.5M | 39.48%32.5M | 52.66%-16M |
| -Change in other current liabilities | 236.59%5.6M | 152.50%4.2M | 166.67%1.6M | -94.74%200K | -116.00%-400K | -173.21%-4.1M | -205.26%-8M | 31.43%-2.4M | 192.31%3.8M | 1,150.00%2.5M |
| -Change in other working capital | -94.30%-626.8M | -391.84%-218.3M | 2,972.41%166.6M | -74.56%-659.3M | 705.76%84.2M | 74.02%-322.6M | -62.13%74.8M | 92.56%-5.8M | -13.32%-377.7M | 98.65%-13.9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.42%455.2M | 53.27%124.15M | 67.44%163.61M | -0.43%97.65M | -28.87%69.79M | 92.85%374.9M | 1.75%81M | 786.11%97.71M | 84.10%98.07M | 94.32%98.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -893.07%-160.2M | -142.31%-30.54M | -485.64%-55.64M | -210.52%-30.93M | 38.85%-43.09M | 101.67%20.2M | 223.28%72.19M | 89.26%-9.5M | 119.37%27.98M | 92.31%-70.47M |
| Net PPE purchase and sale | -5.75%-165.5M | -1.88%-42.96M | 8.71%-40.17M | -22.01%-42.22M | -12.39%-40.15M | -38.99%-156.5M | -21.43%-42.17M | -59.62%-44.01M | -100.86%-34.6M | -8.00%-35.73M |
| Net intangibles purchase and sale | ---23.4M | --10K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | 102.52%2.5M | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -83.52%28.7M | -88.91%12.41M | -76.97%7.95M | -81.96%11.29M | 91.53%-2.94M | 117.52%174.2M | 598.97%111.86M | -13.51%34.51M | 148.66%62.58M | 96.07%-34.75M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -893.07%-160.2M | -142.31%-30.54M | -485.64%-55.64M | -210.52%-30.93M | 38.85%-43.09M | 101.67%20.2M | 223.28%72.19M | 89.26%-9.5M | 119.37%27.98M | 92.31%-70.47M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 48.59%-218.8M | 86.91%-26.25M | -260.88%-95.99M | 52.36%-96.59M | -99.51%21K | -143.71%-425.6M | -131.62%-200.57M | -203.21%-26.6M | -67.10%-202.74M | -99.64%4.31M |
| Net issuance payments of debt | 20.00%-400K | 72.85%-41K | -4.24%-123K | -1.72%-118K | -2.61%-118K | -100.04%-500K | 1.31%-151K | -4.42%-118K | 22.67%-116K | -100.01%-115K |
| Net common stock issuance | 52.51%-203.6M | 99.99%-14K | -358.88%-97.84M | 51.30%-101M | ---4.75M | -98.75%-428.7M | -120.48%-199.97M | ---21.32M | ---207.41M | --0 |
| Proceeds from stock option exercised by employees | 3.78%19.2M | -9.74%3.91M | 9.79%5.1M | -8.12%4.68M | 24.43%5.51M | 5.11%18.5M | -1.14%4.33M | -2.66%4.65M | 19.45%5.1M | 5.91%4.42M |
| Net other financing activities | -128.19%-34M | -529.51%-30.1M | 68.10%-3.13M | ---152K | ---617K | -6.43%-14.9M | -3,756.45%-4.78M | 27.00%-9.81M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 48.59%-218.8M | 86.91%-26.25M | -260.88%-95.99M | 52.36%-96.59M | -99.51%21K | -143.71%-425.6M | -131.62%-200.57M | -203.21%-26.6M | -67.10%-202.74M | -99.64%4.31M |
| Net cash flow | ||||||||||
| Beginning cash position | -6.93%404.4M | -10.06%412.19M | 4.41%407.72M | -6.62%433.75M | -6.94%404.37M | -7.77%434.5M | -11.56%458.32M | -34.58%390.48M | -42.13%464.5M | -7.77%434.54M |
| Current changes in cash | 349.84%76.2M | 242.17%67.36M | -80.54%11.99M | 61.05%-29.87M | -16.38%26.72M | 22.98%-30.5M | 27.71%-47.38M | 171.51%61.61M | 63.92%-76.69M | -90.16%31.96M |
| Effect of exchange rate changes | 2,200.00%9.2M | 257.46%10.22M | -220.80%-7.52M | 43.70%3.83M | 233.42%2.66M | -86.67%400K | 64.27%-6.49M | -17.06%6.22M | -60.73%2.67M | -129.02%-2M |
| End cash Position | 21.12%489.8M | 21.12%489.8M | -10.06%412.19M | 4.41%407.72M | -6.62%433.75M | -6.93%404.4M | -6.93%404.4M | -11.56%458.32M | -34.58%390.48M | -42.13%464.5M |
| Free cash flow | 22.00%266.2M | 109.73%81.25M | 86.37%99.97M | -12.71%55.37M | -52.53%29.62M | 172.41%218.2M | -10.53%38.74M | 424.15%53.64M | 76.50%63.43M | 258.26%62.39M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.